Sama Atta Gitti, Rayan Zaidan Khalaf, Abdulhadi Alrubaie
{"title":"The Effect of Melatonin on Body Weight and the Potential use of Melatonin as an Anti-Obesity Agent","authors":"Sama Atta Gitti, Rayan Zaidan Khalaf, Abdulhadi Alrubaie","doi":"10.47723/kcmj.v19i2.925","DOIUrl":null,"url":null,"abstract":"Background: obesity is a major global health problem with more than 200 million obese men and almost 300 million obese women. Melatonin is a well-known molecule for its involvement in circadian rhythm regulation and has multiple pathological actions including control of appetite, sleep wake cycle and metabolic syndrome.\nAim: to estimate the effect of melatonin supplements on obese patients on a calorie restricted diet in comparison to patients on lifestyle measures only in the form of weight loss, waist circumference and sleep quality.\nSubjects and Method: one hundred patients with body mass index > 24 were collected, fifty patients were started on melatonin 5 mg with calorie restricted diet and they were compared to fifty patients who were kept on lifestyle measures. After twelve weeks, patients were re-assessed for weight, waist circumference and sleep duration and quality and the development of any side effects. Data analyzed using paired t test.\nResults: patients’ group who were treated with melatonin has shown significant reduction in body weight (91.58. Vs 92.88, p value <0.0004) and waist circumference (99.36 +- 10.73 vs 101 +-10.51, p value< 0.0064). Patients treated with melatonin show improved insomnia severity index (5.47+-0.8 vs 9.08 +-3.58, p value <0.0001). 60% of patients noticed decreased appetite,35% reported daytime sleepiness and fatigue, 25% had dizziness and 20% had mild nausea.\nConclusion: Melatonin significantly reduces the body weight, waist circumference and appetite more than placebo, it has been shown to be safe supplement and helpful in patients with sleep disturbance and obesity.","PeriodicalId":34748,"journal":{"name":"mjlh klyh Tb lkndy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"mjlh klyh Tb lkndy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47723/kcmj.v19i2.925","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: obesity is a major global health problem with more than 200 million obese men and almost 300 million obese women. Melatonin is a well-known molecule for its involvement in circadian rhythm regulation and has multiple pathological actions including control of appetite, sleep wake cycle and metabolic syndrome.
Aim: to estimate the effect of melatonin supplements on obese patients on a calorie restricted diet in comparison to patients on lifestyle measures only in the form of weight loss, waist circumference and sleep quality.
Subjects and Method: one hundred patients with body mass index > 24 were collected, fifty patients were started on melatonin 5 mg with calorie restricted diet and they were compared to fifty patients who were kept on lifestyle measures. After twelve weeks, patients were re-assessed for weight, waist circumference and sleep duration and quality and the development of any side effects. Data analyzed using paired t test.
Results: patients’ group who were treated with melatonin has shown significant reduction in body weight (91.58. Vs 92.88, p value <0.0004) and waist circumference (99.36 +- 10.73 vs 101 +-10.51, p value< 0.0064). Patients treated with melatonin show improved insomnia severity index (5.47+-0.8 vs 9.08 +-3.58, p value <0.0001). 60% of patients noticed decreased appetite,35% reported daytime sleepiness and fatigue, 25% had dizziness and 20% had mild nausea.
Conclusion: Melatonin significantly reduces the body weight, waist circumference and appetite more than placebo, it has been shown to be safe supplement and helpful in patients with sleep disturbance and obesity.
背景:肥胖是一个主要的全球健康问题,有2亿多男性肥胖,近3亿女性肥胖。褪黑素是一种众所周知的参与昼夜节律调节的分子,具有多种病理作用,包括控制食欲、睡眠-觉醒周期和代谢综合征。目的:与仅以减肥、腰围和睡眠质量为形式的生活方式测量的患者相比,评估褪黑素补充剂对热量限制饮食的肥胖患者的影响。受试者和方法:收集100名体重指数>24的患者,50名患者开始服用褪黑激素5mg的热量限制饮食,并与50名保持生活方式的患者进行比较。12周后,对患者的体重、腰围、睡眠时间和质量以及任何副作用的发展进行重新评估。使用配对t检验分析数据。结果:接受褪黑激素治疗的患者组体重显著减轻(91.58。Vs 92.88,p值<0.0004)和腰围(99.36+-10.73 Vs 101+10.51,p值<0.0064)。接受褪黑素治疗的患者失眠严重程度指数有所改善(5.47+-0.8 Vs 9.08+-3.58,p值<0.0001)。60%的患者食欲下降,35%的患者白天嗜睡和疲劳,25%的患者头晕,20%的患者轻度恶心。结论:褪黑素比安慰剂更能显著降低体重、腰围和食欲,是一种安全的补充剂,对睡眠障碍和肥胖患者有帮助。